Identification of a committed precursor to the tissue-resident memory T cell fate — ASN Events

Identification of a committed precursor to the tissue-resident memory T cell fate (#59)

Julia E Prier 1 , Simone L Park 1 , Susan N Christo 1 , David Freestone 1 , Gabrielle T Belz 2 , Francis R Carbone 1 , Florent Ginhoux 3 , Laura K Mackay 1
  1. Department of Microbiology and Immunology, The University of Melbourne, The Peter Doherty Institute for Infection and Immunity, Melbourne, Victoria, Australia
  2. Walter and Eliza Hall Institute of Medical Research, Melbourne, Victoria, Australia
  3. Singapore Immunology Network (SIgN), Agency for Science, Technology and Research, Singapore

Tissue-resident memory T cells (TRM) persist in barrier tissues where they provide site-specific immune protection. However, the cell fate decisions and lineage pathways that lead to TRM commitment over conventional memory T cell subsets, remains unclear. Here, we found that a distinct TRM precursor (proTRM) can be found in the secondary lymphoid organs early following infection. We developed a novel barcoding system where cellular division could be used as an unbiased proxy for cell fate, which allowed the permanent identification of T cells after infection based on the number of cell divisions experienced during T cell priming. Using this system, we show that proTRM undergo relatively fewer rounds of cellular division in the skin-draining lymph node after HSV infection, and these cells preferentially give rise to TRM in the tissue. Transcriptional profiling showed that a substantial number of TRM core signature genes are upregulated on proTRM early after T cell priming in the lymphoid organs, and identified markers that distinguish these cells prior to further differentiation to the TRM phenotype in peripheral tissues. Indexed single cell RNA sequencing allowed us to determine the proTRM transcriptional program and to establish the split between TRM and conventional memory T cell fates. These findings provide a platform for manipulation of proTRM cells to enhance tissue-specific protection against infectious diseases and cancers or reduce autoimmune-related disease burden.

#ASI2017QLD